We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
576
Global Payments
GPN
$23B
$1.17M 0.03%
22,644
-43,104
-66% -$2.21M
ICPT
577
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.16M 0.03%
4,812
+698
+17% +$186K
CSL icon
578
Carlisle Companies
CSL
$14.6B
$1.16M 0.03%
+11,563
New +$1.13M
FUL icon
579
H.B. Fuller
FUL
$2.97B
$1.15M 0.03%
28,412
-75
-0.3% -$3.17K
FXR icon
580
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
$1.15M 0.03%
38,669
+816
+2% +$25.3K
SRCL
581
DELISTED
Stericycle Inc
SRCL
$1.15M 0.03%
8,580
-913
-10% -$125K
JNPR
582
DELISTED
Juniper Networks
JNPR
$1.14M 0.03%
44,001
+781
+2% +$20.5K
LRCX icon
583
Lam Research
LRCX
$367B
$1.14M 0.03%
140,140
-12,620
-8% -$99.1K
TR icon
584
Tootsie Roll Industries
TR
$2.93B
$1.13M 0.03%
48,474
+38,276
+375% +$886K
SCHW
585
Charles Schwab
SCHW
$183B
$1.12M 0.03%
34,289
+20,064
+141% +$634K
BGG
586
DELISTED
Briggs & Stratton Corp.
BGG
$1.11M 0.03%
57,739
-1
-0% -$20
SHW icon
587
Sherwin-Williams
SHW
$82.7B
$1.11M 0.03%
12,096
+2,850
+31% +$270K
MU icon
588
Micron Technology
MU
$930B
$1.1M 0.03%
58,568
+21,567
+58% +$575K
DEO icon
589
Diageo
DEO
$49B
$1.1M 0.03%
9,472
-1,354
-13% -$154K
GLOG
590
DELISTED
GASLOG LTD
GLOG
$1.1M 0.03%
55,083
+39,308
+249% +$830K
VO icon
591
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$1.1M 0.03%
34,488
KERX
592
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.09M 0.03%
109,390
-842
-0.8% -$9.03K
TRN icon
593
Trinity Industries
TRN
$2.48B
$1.09M 0.03%
57,360
-29,323
-34% -$657K
FIW icon
594
First Trust Water ETF
FIW
$1.85B
$1.09M 0.03%
34,726
+321
+0.9% +$10.3K
HSY icon
595
Hershey
HSY
$35.5B
$1.09M 0.03%
12,236
+95
+0.8% +$8.96K
OGCP
596
Empire State Realty Series 60
OGCP
$1.47B
$1.09M 0.03%
64,422
+10,737
+20% +$192K
SURE icon
597
AdvisorShares Insider Advantage ETF
SURE
$56.6M
$1.08M 0.03%
18,977
+3,608
+23% +$209K
TER icon
598
Teradyne
TER
$57.6B
$1.08M 0.03%
56,239
+4,741
+9% +$94.7K
AET
599
DELISTED
Aetna Inc
AET
$1.08M 0.03%
8,502
-2,180
-20% -$249K
AJRD
600
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.08M 0.03%
52,544
-5,230
-9% -$109K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.